Key facts
CollPlant Biotechnologies Ltd
New Form D on file · 2026-07-20 · the record
What the record says
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 862 filings in Other Health Care, totalled by week. The dot is this raise, $10.40M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
The Company intends to use net proceeds for general corporate purposes, including working capital, R&D programs, and evaluating strategic business combinations and other strategic transactions, the amount of which cannot currently be estimated.
Company officers on record
On the filing as: Executive Officer, Director.
Yehiel Tal is named as Chief Executive Officer and Interim Chairman of the Board of Directors on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
On the filing as: Executive Officer.
Eran Rotem is named as Deputy Chief Executive Officer and Chief Financial Officer on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
On the filing as: Executive Officer.
Oren Fahimipoor is named as Vice President, Operations on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
On the filing as: Executive Officer.
Philippe Bensimon is named as Vice President, Regulatory Affairs and Quality Assurance on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
On the filing as: Executive Officer.
Jasmine Seror is named as Vice President, Product Development on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
On the filing as: Executive Officer.
Bowman Bagley is named as Vice President, Commercial North America on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
On the filing as: Executive Officer.
Bar Abelis is named as Vice President, Legal on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
Abraham Havron is named as Director on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
Elan Penn is named as Director on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
Joseph Zarzewsky is named as Director on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
Hugh Evans is named as Director on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
Alisa Lask is named as Director on the Form D that CollPlant Biotechnologies Ltd filed with the SEC on 20 July 2026, one of 12 people that filing names.
12 people named on the filing — 7 holding an executive role and 5 as directors only.
Named as of the 2026-07-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 12 people named on the filing — 7 holding an executive role and 5 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
Want the whole picture on CollPlant Biotechnologies Ltd?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on CollPlant Biotechnologies Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CollPlant Biotechnologies Ltd covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The full profile
Source Check, INVEST, RECRUIT and Press Requests on CollPlant Biotechnologies Ltd
- Source Check — verify Eran Rotem's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Eran Rotem for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CollPlant Biotechnologies LtdYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind CollPlant Biotechnologies Ltd: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.